SREBF2 and cancer: While SREBP1a and SREBP1c show selectivity towards regulation of fatty acid biosynthesis, SREBP2 controls the expression of enzymes of the mevalonate pathway (MVP), which has multiple metabolic outputs that connect to biosynthetic and signalling processes in cancer, including providing substrates for the prenylation of small G proteins [20].